Many of the Australian BioCommons team and partners working on our projects will be presenting at the next eResearch conference. Here’s a grab of ways to hear about our ongoing developments…
Read MoreMeet our Associate Directors and learn what excites them about our work.
Read MoreThe Australian BioCommons is identifying community-supported bioinformatics tools used for assembly of non-model organism reference genomes, and subsequently coordinating the install, optimisation and documentation of these tools across Australian computing facilities, including the national (tier 1) high performance computing centres. A major aim is to provide reusable and reproducible methods that can be applied across these and other infrastructures available to the genome assembly community.
Read MoreThe Australian BioCommons is proud to announce the signing of a contract with Bioplatforms Australia to deliver enhanced coordination in the planning and development of research infrastructure supporting bioinformatics in life science research. The $20M NCRIS investment will improve the ability of many of Australia’s best researchers to undertake leading edge bioinformatics analyses. The Australian BioCommons is partnering with a network of Australian and global bioinformatics and data intensive research groups to address high priority challenges through to 2023.
Read MoreA new Collaboration Strategy between ELIXIR and the Australian BioCommons seeks to create a cooperative plan to exploit international synergies between the two research infrastructures. This three-year collaboration will actively involve Australian BioCommons in many of the activities related to the European life science infrastructures.
Read MoreIndustry-leading bioinformatics ecosystem provider, Seven Bridges, sparked international interest this week in the multinational genomic cancer research project that Australian BioCommons contributes to. Their media release Seven Bridges Announces International Collaboration Focused on Personalized Treatment for Kids with Cancer documented how our collaboration will help researchers better understand rare pediatric brain cancer subtypes and improve interventions for patients and their families. Working with Seven Bridges, The Gabriella Miller Kids First Data Resource Center (Kids First DRC), ZERO Childhood Cancer (ZERO), the Children’s Brain Tumor Tissue Consortium (CBTTC) and the Australian Research Data Commons (ARDC), we are establishing internationally federated computational infrastructure that will enable the harmonisation of pediatric cancer data from ZERO Australia with the extensive genomic datasets from CBTTC and Kids First DRC.
Read MoreSeven Bridges, the industry-leading bioinformatics ecosystem provider, today announced a collaborative partnership between The Gabriella Miller Kids First Data Resource Center (Kids First DRC), ZERO Childhood Cancer (ZERO), the Children’s Brain Tumor Tissue Consortium (CBTTC), the Australian BioCommons and the Australian Research Data Commons (ARDC). The multinational genomic cancer research project aims to establish internationally federated computational infrastructure that will enable the harmonization of pediatric cancer data from ZERO Australia with the extensive genomic datasets from CBTTC and Kids First DRC. Through this collaboration, researchers hope to better understand rare pediatric brain cancer subtypes and improve interventions for patients and their families.
Read MoreAustralian researchers can now rapidly analyse their SARS-CoV-2 data using published tools and workflows by using a new dedicated Galaxy COVID-19 compute node hosted at Pawsey Supercomputing Centre. The ability of Galaxy Australia and Pawsey to jointly deliver this enabling data analytics platform has been made possible as part of the COVID-19 Accelerated Access Initiative in which Australia’s national HPC facilities responded quickly to the pandemic with streamlined, prioritised and expedited access to computation and data resources. NCI Australia and the Pawsey Supercomputing Centre have now announced that the Galaxy COVID-19 compute node would be hosted on Pawsey’s newly deployed Nimbus Cloud, guaranteeing tailored resources for urgent public health research.
Read MoreMembers of our team recently advanced the Australian BioCommons Software and Containers project by participating in two strategic meetings at Pawsey Supercomputing Centre in Perth. The March events drew together partners who are contributing to the national roll out of a common bioinformatics software containerisation and meta-data standard, and a common implementation standard of the open-source container-orchestration system Kubernetes for use by Australian life scientists.
Read MoreResearchers from universities in Germany, Belgium, Australia and the USA, have used publicly available novel coronavirus (COVID-19) genome data and published their analyses using Galaxy, an open source research platform.
The joint paper, written by the international Galaxy team, demonstrates how the COVID-19 genome data can be shared, analysed and reproduced in an efficient and transparent way. In the wake of the COVID-19 pandemic, the researchers showed how Galaxy could facilitate the exchange of data and reproducible workflows between authorities, institutes and laboratories dealing with the virus. The international Galaxy platform, through the provision of highly accessible, globally shared data and analytics platforms, has the potential to transform the way biomedical research is performed. By offering access to data and an open and reproducible analytics environment, the Galaxy platform ensures that progress is no longer limited by access to samples and data.
Read More